Treatment and Prevention of Anemia With Ferrous Sulfate Plus Folic Acid in Children in Goiania - Goias, Brazil

NCT00701246 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 196

Last updated 2014-03-13

No results posted yet for this study

Summary

Iron deficiency anemia is the most common nutritional problem in the world.

The objectives of this study are:

* to evaluate the prevalence of anemia in children from 6 to 24 months of age and the therapeutic and prophylactic response to ferrous sulfate plus folic acid on hemoglobin levels.
* to compare the effect of folic acid supplementation with ferrous sulfate on the linear and weight growth of anemic and non-anemic

Study hypothesis:

* The ferrous sulfate plus folic acid can improve the response on hemoglobin levels.
* The folic acid supplementation with ferrous sulfate have effect on the linear and weight growth of anemic and non-anemic.

Conditions

Interventions

DRUG

ferrous sulfate

DRUG

folic acid

DRUG

placebo (folic acid)

Sponsors & Collaborators

  • Federal University of São Paulo

    collaborator OTHER
  • Ministry of Health, Brazil

    collaborator OTHER_GOV
  • Goiania Municipal Health Department

    collaborator UNKNOWN
  • Universidade Federal de Goias

    lead OTHER

Principal Investigators

  • Maria Claret CM Hadler, PhD Sciences · Universidade Federal de Goias

  • Dirce M Sigulem, MD, PhD · Federal University of São Paulo

  • Maria de Fátima C Alves, PhD · Universidade Federal de Goias

  • Vinícius M Torres, MD · Vila São José Bento Cotolengo

  • Daniela AM Dias, MSc. · Faculty of Nutrition of Federal University of Goias

  • Andréa Sugai, PhD. · Faculty of Nutrition - Federal University of Goias

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2006-03-31
Completion
2006-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00701246 on ClinicalTrials.gov